Anti-mutant CALR Antibody Preparation for Clinical Manufacture for Patients with Myelofibrosis

Read full text
Authors: Therapeutic Innovation Australia
Cited by: 0

Fields of Study & Subjects

Myeloproliferative Neoplasms: Diagnosis and Treatment Monoclonal and Polyclonal Antibodies Research Biosimilars and Bioanalytical Methods

Publication details

Journal / source
Therapeutic Innovation Australia
Publication date
17 February 2026
Language
EN